Revlimid Maintenance Therapy: Three Major Studies Clarify The Benefits And Risks The Myeloma Beacon In two of the three trials, the initial treatment also included a stem cell transplant. After the initial treatment, patients were randomly assigned to take either Revlimid or a placebo on a regular basis until they relapsed. |
